| 141 | Good Clinical Practice and Human Subject Protection Training Program 2019 | | 13/10/2021 11:09:32 | |
| 142 | Good clinical practice and human subject protection training program 2020 | | 13/10/2021 11:18:44 | |
| 143 | CITI Conflicts of Interest | | 13/10/2021 11:35:57 | |
| 144 | Good Clinical Practice Course for Clinical Trials Involving Drugs (ICH focus) | | 13/10/2021 11:37:22 | |
| 145 | IRB members, Researchers, Faculty members - Basic/Refresher | | 13/10/2021 12:43:59 | |
| 146 | Good Clinical Practice Course for Clinical Trials Involving Drugs (ICH focus) | | 13/10/2021 12:37:32 | |
| 147 | Good Clinical Practice Course for Clinical Trials Involving Devices (international focus) | | 13/10/2021 12:40:50 | |
| 148 | Good Clinical Practice (U.S. FDA Focus) | | 13/10/2021 12:41:34 | |
| 149 | CITI Conflicts of Interest | | 13/10/2021 12:43:22 | |
| 150 | Citi | | 13/10/2021 14:33:58 | |
| 151 | CITI5 | | 05/11/2021 16:25:22 | |
| 152 | CITI4 | | 05/11/2021 16:25:39 | |
| 153 | CITI3 | | 05/11/2021 16:26:26 | |
| 154 | CITI2 | | 05/11/2021 16:26:41 | |
| 155 | CITI1 | | 05/11/2021 16:26:52 | |
| 156 | Good Clinical Practice & Human Subject Protection Training Program 2020 | | 13/10/2021 19:18:34 | |
| 157 | GCP | | 13/10/2021 19:32:47 | |
| 158 | GCP | | 13/10/2021 19:33:22 | |
| 159 | GCP | | 13/10/2021 19:33:38 | |
| 160 | CITI program (IRB) | | 13/10/2021 19:59:23 | |
